文献速递生殖医学妇科

BRCA2突变携带者的抗苗勒管激素水平较低

Antimüllerian hormone levels are lower in BRCA2 mutation carriers.
PubMed 文献 · Fertil Steril · 2017-01-01

前瞻性队列研究纳入195名育龄女性,比较BRCA1、BRCA2突变携带者、BRCA阴性高危女性和低危对照的AMH水平。校正混杂因素后,BRCA2携带者AMH较对照低33%且AMH<1 ng/mL的比值比升高;BRCA1携带者与对照相似。

要点

  • BRCA2携带者AMH较低危对照低33%,AMH<1 ng/mL的比值比升高。
  • BRCA1携带者及BRCA阴性女性AMH与对照相似。
  • 年轻规律月经的BRCA阴性女性AMH较对照低42%。

核心结论

  • BRCA2突变携带者的AMH水平显著低于低危对照女性,该结果在所有模型中稳定。
  • BRCA阴性女性AMH也较低,但仅见于年轻且规律月经女性的限制性模型。
  • 与早期分析不同,BRCA1携带者AMH与低危对照相似,可能源于研究人群差异。

研究设计与样本

  • 前瞻性队列研究,纳入195名有子宫和双侧卵巢的育龄女性。
  • 分为四组:BRCA1携带者55名、BRCA2携带者50名、BRCA阴性女性26名、低危对照64名。
  • 干预为自采干血斑,主要结局指标为AMH水平。

主要发现

  • 校正混杂因素后,BRCA2携带者AMH较对照低33%,且AMH<1 ng/mL的比值比升高。
  • BRCA1携带者和BRCA阴性女性AMH水平与对照相似。
  • 限制于小于40岁且规律月经的女性时,BRCA2携带者AMH仍显著较低且低AMH可能性增加。
  • 同一限制组中,BRCA阴性女性AMH较对照低42%。
  • BRCA1携带者在该限制组中AMH无差异。

关键数值与推荐

  • 原文未报告具体比值比数值及置信区间。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • BRCA1携带者AMH与低危对照相似的结果可能源于所研究人群的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare antimüllerian hormone (AMH) levels in women at high risk for hereditary breast and ovarian cancer compared with healthy low-risk control women. DESIGN: Prospective cohort. SETTING: Not applicable. PATIENT(S): Reproductive-age women with a uterus and both ovaries were analyzed in four groups: BRCA1 mutation carriers, BRCA2 carriers, BRCA-negative women, and low-risk controls. INTERVENTION(S): Self-collected dried blood spot. MAIN OUTCOME MEASURE(S): AMH levels. RESULT(S): One hundred ninety-five women were included: 55 BRCA1 carriers, 50 BRCA2 carriers, 26 BRCA negative women, and 64 low-risk controls. After adjusting for confounders, BRCA2 carriers had AMH levels that were 33% lower than control women and an increased odds of having AMH <1 ng/mL. BRCA1 carriers and BRCA-negative women had AMH levels similar to control women. When analysis was restricted to regularly menstruating women younger than 40 years of age, BRCA2 carriers continued to demonstrate significantly lower AMH levels and increased likelihood of low AMH. Also, in this restricted group, BRCA-negative women demonstrated AMH levels that were 42% lower than control women. No difference in AMH was observed for BRCA1 carriers. CONCLUSION(S): We observed significantly lower AMH levels among BRCA2 carriers compared with low-risk control women. These results were stable across all models. BRCA-negative women also had lower AMH values, but only in models restricted to young regularly menstruating women. In contrast to earlier analyses, BRCA1 carriers had AMH values that were similar to low-risk control women, but this may be due to differences in the population studied.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Johnson L, Sammel MD, Domchek S, et al. Antimüllerian hormone levels are lower in BRCA2 mutation carriers. Fertil Steril. 2017. PMID: 28476184. doi:10.1016/j.fertnstert.2017.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。